Fertility and Sterility
Volume 94, Issue 5 , Pages 1627-1631, October 2010

Cancers, infections, and endocrine diseases in women with endometriosis

  • Julie Anne L. Gemmill, B.A.

      Affiliations

    • Program in Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
  • ,
  • Pamela Stratton, M.D.

      Affiliations

    • Program in Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
  • ,
  • Sean D. Cleary, Ph.D.

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health and Health Services, George Washington University, Washington, DC
  • ,
  • Mary Lou Ballweg, B.A.

      Affiliations

    • Endometriosis Association International Headquarters, Milwaukee, Wisconsin
  • ,
  • Ninet Sinaii, Ph.D.

      Affiliations

    • Program in Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
    • Biostatistics and Clinical Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland
    • Corresponding Author InformationReprint requests: Ninet Sinaii, Ph.D., Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, 10 Center Drive, Building 10, Room 2N-228, Bethesda, Maryland 20891-1871 (FAX: 301-496-0457).

Received 14 April 2009; received in revised form 14 July 2009; accepted 29 July 2009. published online 27 November 2009.

Objective

To assess the prevalence of patient-reported, physician-diagnosed comorbid conditions in women with endometriosis.

Design

Cross-sectional study of self-reported survey data.

Setting

Academic research.

Patient(s)

Four thousand three hundred thirty-one Endometriosis Association (EA) members reporting surgically diagnosed endometriosis.

Intervention(s)

None.

Main Outcome Measure(s)

Self-reported, physician-diagnosed infectious diseases, cancers, and endocrine diseases.

Result(s)

Nearly two-thirds of women reported one or more of the assessed conditions. Recurrent upper respiratory infections and recurrent vaginal infections were common and more likely in women responding to the EA survey. Melanoma was reported by 0.7% (n=29), breast cancer by 0.4% (n=16), and ovarian cancer by 0.2% (n=10). While ovarian cancer and melanoma were significantly more common than in the general population, breast cancer was surprisingly less common. Addison's disease and Cushing's syndrome were rare (0.2% and 0.1%, respectively).

Conclusion(s)

Respondents reported a higher prevalence of recurrent upper respiratory or vaginal infections, melanoma, and ovarian cancer than the general population. These findings document other potential associations related to the immune system, which may help focus future research into this disease.

Key Words: Cancer, infectious disease, endocrine disease, endometriosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 J.A.L.G. has nothing to disclose. P.S. has nothing to disclose. S.D.C. has nothing to disclose. M.L.B. has nothing to disclose. N.S. has nothing to disclose.

 The 1998 Endometriosis Association Survey was supported by an unrestricted educational grant from Zeneca Pharmaceuticals. The research for this study was supported by the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Clinical Center, National Institute of Health, Bethesda, Maryland, and the Endometriosis Association, International Headquarters, Milwaukee, Wisconsin.

PII: S0015-0282(09)03880-1

doi:10.1016/j.fertnstert.2009.07.1698

Fertility and Sterility
Volume 94, Issue 5 , Pages 1627-1631, October 2010